malt66, with these major distinctions...
If PURE's SDC is only a disinfectant and will not kill spores, but as Ygiene is a sterilant which not only disinfects but kills the spores as well, then I think PURE has no other choice except to try to form some kind of a partnership or union between the two as eventually, the current clients of PURE will definitely learn of such a greater product out there than what they currently have. With PURE already trading on the NASDAQ, I'm sure they have a huge customer base. In my opinion, this is what makes sense to me if I was “King of PURE” to control what they do.
I wasn't really aware of this other major distinction in that... as a disinfectant, no EPA approval is needed as there are many disinfectants available in the market place. More important though from what you stated... BONU's Ygiene 206 has EPA approval which carries much more weight when you try to obtain a significant contract be it with a hospital, remedial or government entity.
This is awesome for BONU to position the company for some forward movement for company growth for the second half of the year which coincides with what they have filed. It would not surprise me one bit if we saw a major contract from a major company. Only some quick food for thought.
v/r
Sterling
